Status:
COMPLETED
Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40+ years
Brief Summary
The aim of this postmarketing surveillance is to obtain further information about the tolerability and efficacy of Berodual® metered-dose inhaler in the treatment of chronic obstructive respiratory tr...
Eligibility Criteria
Inclusion
- Patients of either sex over 40 years with the symptoms of a chronic obstructive airways disease
- Only patients which have not been treated with Berodual® within the last year should be included
Exclusion
- Contraindications listed in the Instructions for Use/Summary of Product Characteristics for Berodual® metered-dose inhaler
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
834 Patients enrolled
Trial Details
Trial ID
NCT02232594
Start Date
January 1 2000
Last Update
September 5 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.